3-[4-[2-[5-(3,5-Dimethyl-1,2-oxazol-4-yl)-1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]ethyl]phenoxy]-N,N-dimethylpropan-1-amine

CAS: 1962928-22-8

Ref. 3D-MDD92822

Información del producto

• Nombre: 3-[4-[2-[5-(3,5-Dimethyl-1,2-oxazol-4-yl)-1-(2-morpholin-4-ylethyl)benzimidazol-2-yl]ethyl]phenoxy]-N,N-dimethylpropan-1-amine
• Marca: Biosynth
• Descripción: Tocilizumab is a monoclonal antibody that inhibits the effects of TNF-α, IL-6, and IL-8. It prevents the activation of the downstream inflammatory genes, which are involved in the pathogenesis of cancer and other diseases. Tocilizumab binds to bromodomains on proteins such as p-tefb, which is involved in transcriptional regulation and deuterated Tocilizumab can be used to normalize inflammatory gene expression. This drug has been shown to be effective against aneurysms and other conditions caused by inflammation.

Propiedades químicas

• Peso molecular: 531.7 g/mol
• Fórmula: C₃₁H₄₁N₅O₃
• Pureza: Min. 95%